Novel biobased polyester
US-2024327659-A1 · Oct 3, 2024 · US
US12428507B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12428507-B2 |
| Application number | US-201716627202-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 31, 2017 |
| Priority date | Jun 29, 2017 |
| Publication date | Sep 30, 2025 |
| Grant date | Sep 30, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure relates to an encapsulant film made from a curable composition comprising: (A) a polyolefin polymer; (B) an organic peroxide; (C) a silane coupling agent; and (D) a co-agent comprising a monocyclic organosiloxane of formula (I).
Opening claim text (preview).
What is claimed is: 1. A curable composition for forming an encapsulant film, wherein the composition comprises: a) from 85 wt % to 99.88 wt % of an ethylene/1-octene copolymer comprising of greater than 60 wt % ethylenic units and at least 30 wt % 1-octene units and having a density of from 0.870 g/cc to 0.890 (ASTM D792) and a melt index of from 1.0 g/10 min to 50.0 g/10 min (ASTM D1238, at 190° C./2.16 kg); b) from 0.1 wt % to 5 wt % of an organic peroxide; c) from 0.01 wt % to 2 wt % of a silane coupling agent; and d) from 0.01 wt % to 5 wt % of a co-agent comprising a monocyclic organosiloxane of formula (I): wherein subscript n is an integer greater than or equal to 3; each R 1 is independently a (C 2 -C 4 )alkenyl; and each R 2 is independently H, (C 1 -C 4 )alkyl, phenyl, or R 1 . 2. The composition of claim 1 , wherein the monocyclic organosiloxane of formula (I) is further described by any one of limitations (i) to (vi): (i) subscript n is 3; (ii) each R 1 is independently a (C 2 -C 3 )alkenyl; and each R 2 is independently H, (C 1 -C 2 )alkyl, or (C 2 -C 3 )alkenyl; (iii) each R 1 is vinyl; and each R 2 is independently (C 1 -C 2 )alkyl; (iv) each R 1 is vinyl; and each R 2 is methyl; (v) each R 1 is allyl; and each R 2 is independently (C 1 -C 2 )alkyl; (vi) each R 1 is allyl; and each R 2 is methyl. 3. The composition of claim 1 , wherein the monocyclic organosiloxane of formula (I) is further described by any one of limitations (i) to (vi): (i) subscript n is 4; (ii) each R 1 is independently a (C 2 -C 3 )alkenyl; and each R 2 is independently H, (C 1 -C 2 )alkyl, or (C 2 -C 3 )alkenyl; (iii) each R 1 is vinyl; and each R 2 is independently (C 1 -C 2 )alkyl; (iv) each R 1 is vinyl; and each R 2 is methyl; (v) each R 1 is allyl; and each R 2 is independently (C 1 -C 2 )alkyl; (vi) each R 1 is allyl; and each R 2 is methyl. 4. The composition of claim 1 , wherein the monocyclic organosiloxane of formula (I) is further described by any one of limitations (i) to (vi): (i) subscript n is 5 or 6; (ii) each R 1 is independently a (C 2 -C 3 )alkenyl; and each R 2 is independently H, (C 1 -C 2 )alkyl, or (C 2 -C 3 )alkenyl; (iii) each R 1 is vinyl; and each R 2 is independently (C 1 -C 2 )alkyl; (iv) each R 1 is vinyl; and each R 2 is methyl; (v) each R 1 is allyl; and each R 2 is independently (C 1 -C 2 )alkyl; (vi) each R 1 is allyl; and each R 2 is methyl. 5. The composition of claim 1 , wherein the monocyclic organosiloxane of formula (I) is selected from the group consisting of: 1,3,5,7-tetravinyl-1,3,5,7-tetramethylcyclotetrasiloxane; 1,3,5-trivinyl-1,3,5-trimethylcyclotrisiloxane; 1,3,5,7,9-pentavinyl-1,3,5,7,9-pentamethylcyclopentasiloxane; and combinations thereof. 6. An encapsulant film comprising a crosslinked polymeric composition comprising the reaction product of: a) from 85 wt % to 99.88 wt % of an ethylene/1-octene copolymer comprising of greater than 60 wt % of ethylenic units and at least 30 wt % 1-octene units and having a density of from 0.870 g/cc to 0.890 g/cc (ASTM D792) and a melt index of from 1.0 g/10 min to 50.0 g/10 min (ASTM D1238, at 190° C./2.16 kg); b) from 0.1 wt % to 5 wt % of an organic peroxide; c) from 0.01 wt % to 2 wt % of a silane coupling agent; and d) from 0.01 wt % to 5 wt % of a co-agent comprising a monocyclic organosiloxane of formula (I): wherein subscript n is an integer greater than or equal to 3; each R 1 is independently a (C 2 -C 4 )alkenyl; and each R 2 is independently H, (C 1 -C 4 )alkyl, phenyl, or R 1 ; and an average initial glass adhesion of greater than 60 N/cm. 7. The encapsulant film of claim 6 , wherein the monocyclic organosiloxane of formula (I) is further described by any one of limitations (i) to (vi): (i) subscript nis 3; (ii) each R 1 is independently a (C 2 -C 3 )alkenyl; and each R 2 is independently H, (C 1 -C 2 )alkyl, or (C 2 -C 3 )alkenyl; (iii) each R 1 is vinyl; and each R 2 is independently (C 1 -C 2 )alkyl; (iv) each R 1 is vinyl; and each R 2 is methyl; (v) each R 1 is allyl; and each R 2 is independently (C 1 -C 2 )alkyl; (vi) each R 1 is allyl; and each R 2 is methyl. 8. The encapsulant film of claim 6 , wherein the monocyclic organosiloxane of formula (I) is further described by any one of limitations (i) to (vi): (i) subscript n is 4; (ii) each R 1 is independently a (C 2 -C 3 )alkenyl; and each R 2 is independently H, (C 1 -C 2 )alkyl, or (C 2 -C 3 )alkenyl; (iii) each R 1 is vinyl; and each R 2 is independently (C 1 -C 2 )alkyl; (iv) each R 1 is vinyl; and each R 2 is methyl; (v) each R 1 is allyl; and each R 2 is independently (C 1 -C 2 )alkyl; (vi) each R 1 is allyl; and each R 2 is methyl. 9. The encapsulant film of claim 6 , wherein the monocyclic organosiloxane of formula (I) is further described by any one of limitations (i) to (vi): (i) subscript n is 5 or 6; (ii) each R 1 is independently a (C 2 -C 3 )alkenyl; and each R 2 is independently H, (C 1 -C 2 )alkyl, or (C 2 -C 3 )alkenyl; (iii) each R 1 is vinyl; and each R 2 is independently (C 1 -C 2 )alkyl; (iv) each R 1 is vinyl; and each R 2 is methyl; (v) each R 1 is allyl; and each R 2 is independently (C 1 -C 2 )alkyl; (vi) each R 1 is allyl; and each R 2 is methyl. 10. The encapsulant film of claim 6 , wherein the monocyclic organosiloxane of formula (I) is selected from the group consisting of: 1,3,5,7-tetravinyl-1,3,5,7-tetramethylcyclotetrasiloxane; 1,3,5-trivinyl-1,3,5-trimethylcyclotrisiloxane; 1,3,5,7,9-pentavinyl-1,3,5,7,9-pentamethylcyclopentasiloxane; and combinations thereof. 11. The encapsulant film of claim 6 , further comprising a volume resistivity of greater than 1.0*10 14 ohm-cm at room temperature. 12. The encapsulant film of claim 6 , further comprising a volume resistivity of greater than 1.0*10 14 ohm-cm at 60° C. 13. An electronic device module comprising: an electronic device, a cover sheet, and the encapsulant film of claim 6 .
Materials of encapsulations · CPC title
containing silicon in a ring · CPC title
containing at least one C=C bond · CPC title
Homopolymers or copolymers of ethene · CPC title
Polyethylene · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.